is berberine a glp-1 receptor agonist Frontiers Berberine as a multi-target therapeutic

PMID: 37873318

Citrulline malate converts to arginine in your body and might offer similar benefits

In vivo experiments showed the peptide rapidly restoring blood flow through collateral vessel activation in models of venous occlusion, an effect closely linked to the NO system and reduction of free radical formation

This allows us to: Target the injury locally (BPC-157) Enhance systemic recovery (TB-500) Reduce inflammation more effectively Accelerate overall healing timelines This dual approach reflects how we think about optimizationnot choosing one tool, but building a protocol that delivers measurable results

For this purpose, a multiskan FC spectrophotometer (Thermo Scientific, Illkirch, France) was used to measure the optical density at 620 nm